Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 02, 2022

Efficacy and Safety of Omecamtiv Mecarbil in Patients With Atrial Fibrillation or Flutter

European Heart Journal


Additional Info

European Heart Journal
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial
Eur Heart J 2022 Mar 23;[EPub Ahead of Print], SD Solomon, BL Claggett, ZM Miao, R Diaz, GM Felker, JJV McMurray, M Metra, R Corbalan, G Filippatos, AR Goudev, V Mareev, P Serpytis, T Suter, MB Yilmaz, F Zannad, S Kupfer, SB Heitner, FI Malik, JR Teerlink

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading